- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
According to our latest study, the global Varicella Vaccine market size was valued at USD 4294.8 million in 2022 and is forecast to a readjusted size of USD 7108.9 million by 2029 with a CAGR of 7.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
This report is a detailed and comprehensive analysis for global Varicella Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Varicella Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Varicella Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Varicella Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Varicella Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Varicella Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Varicella Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Shanghai Institute, BCHT and Changsheng, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Varicella Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Injection
Freeze-Dried Powder
Market segment by Application
Kids Injection
Adults Injection
Major players covered
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Varicella Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Varicella Vaccine, with price, sales, revenue and global market share of Varicella Vaccine from 2018 to 2023.
Chapter 3, the Varicella Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Varicella Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Varicella Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Varicella Vaccine.
Chapter 14 and 15, to describe Varicella Vaccine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Varicella Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Varicella Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Injection
1.3.3 Freeze-Dried Powder
1.4 Market Analysis by Application
1.4.1 Overview: Global Varicella Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Kids Injection
1.4.3 Adults Injection
1.5 Global Varicella Vaccine Market Size & Forecast
1.5.1 Global Varicella Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Varicella Vaccine Sales Quantity (2018-2029)
1.5.3 Global Varicella Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Varicella Vaccine Product and Services
2.1.4 Merck Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Varicella Vaccine Product and Services
2.2.4 GSK Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Shanghai Institute
2.3.1 Shanghai Institute Details
2.3.2 Shanghai Institute Major Business
2.3.3 Shanghai Institute Varicella Vaccine Product and Services
2.3.4 Shanghai Institute Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shanghai Institute Recent Developments/Updates
2.4 BCHT
2.4.1 BCHT Details
2.4.2 BCHT Major Business
2.4.3 BCHT Varicella Vaccine Product and Services
2.4.4 BCHT Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BCHT Recent Developments/Updates
2.5 Changsheng
2.5.1 Changsheng Details
2.5.2 Changsheng Major Business
2.5.3 Changsheng Varicella Vaccine Product and Services
2.5.4 Changsheng Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Changsheng Recent Developments/Updates
2.6 Keygen
2.6.1 Keygen Details
2.6.2 Keygen Major Business
2.6.3 Keygen Varicella Vaccine Product and Services
2.6.4 Keygen Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Keygen Recent Developments/Updates
2.7 Green Cross
2.7.1 Green Cross Details
2.7.2 Green Cross Major Business
2.7.3 Green Cross Varicella Vaccine Product and Services
2.7.4 Green Cross Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Green Cross Recent Developments/Updates
2.8 Biken
2.8.1 Biken Details
2.8.2 Biken Major Business
2.8.3 Biken Varicella Vaccine Product and Services
2.8.4 Biken Varicella Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biken Recent Developments/Updates
3 Competitive Environment: Varicella Vaccine by Manufacturer
3.1 Global Varicella Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Varicella Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Varicella Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Varicella Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Varicella Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Varicella Vaccine Manufacturer Market Share in 2022
3.5 Varicella Vaccine Market: Overall Company Footprint Analysis
3.5.1 Varicella Vaccine Market: Region Footprint
3.5.2 Varicella Vaccine Market: Company Product Type Footprint
3.5.3 Varicella Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Varicella Vaccine Market Size by Region
4.1.1 Global Varicella Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Varicella Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Varicella Vaccine Average Price by Region (2018-2029)
4.2 North America Varicella Vaccine Consumption Value (2018-2029)
4.3 Europe Varicella Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Varicella Vaccine Consumption Value (2018-2029)
4.5 South America Varicella Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Varicella Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Varicella Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Varicella Vaccine Consumption Value by Type (2018-2029)
5.3 Global Varicella Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Varicella Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Varicella Vaccine Consumption Value by Application (2018-2029)
6.3 Global Varicella Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Varicella Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Varicella Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Varicella Vaccine Market Size by Country
7.3.1 North America Varicella Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Varicella Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Varicella Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Varicella Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Varicella Vaccine Market Size by Country
8.3.1 Europe Varicella Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Varicella Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Varicella Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Varicella Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Varicella Vaccine Market Size by Region
9.3.1 Asia-Pacific Varicella Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Varicella Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Varicella Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Varicella Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Varicella Vaccine Market Size by Country
10.3.1 South America Varicella Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Varicella Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Varicella Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Varicella Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Varicella Vaccine Market Size by Country
11.3.1 Middle East & Africa Varicella Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Varicella Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Varicella Vaccine Market Drivers
12.2 Varicella Vaccine Market Restraints
12.3 Varicella Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Varicella Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Varicella Vaccine
13.3 Varicella Vaccine Production Process
13.4 Varicella Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Varicella Vaccine Typical Distributors
14.3 Varicella Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Varicella Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Varicella Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Varicella Vaccine Product and Services
Table 6. Merck Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Varicella Vaccine Product and Services
Table 11. GSK Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Shanghai Institute Basic Information, Manufacturing Base and Competitors
Table 14. Shanghai Institute Major Business
Table 15. Shanghai Institute Varicella Vaccine Product and Services
Table 16. Shanghai Institute Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shanghai Institute Recent Developments/Updates
Table 18. BCHT Basic Information, Manufacturing Base and Competitors
Table 19. BCHT Major Business
Table 20. BCHT Varicella Vaccine Product and Services
Table 21. BCHT Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BCHT Recent Developments/Updates
Table 23. Changsheng Basic Information, Manufacturing Base and Competitors
Table 24. Changsheng Major Business
Table 25. Changsheng Varicella Vaccine Product and Services
Table 26. Changsheng Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Changsheng Recent Developments/Updates
Table 28. Keygen Basic Information, Manufacturing Base and Competitors
Table 29. Keygen Major Business
Table 30. Keygen Varicella Vaccine Product and Services
Table 31. Keygen Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Keygen Recent Developments/Updates
Table 33. Green Cross Basic Information, Manufacturing Base and Competitors
Table 34. Green Cross Major Business
Table 35. Green Cross Varicella Vaccine Product and Services
Table 36. Green Cross Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Green Cross Recent Developments/Updates
Table 38. Biken Basic Information, Manufacturing Base and Competitors
Table 39. Biken Major Business
Table 40. Biken Varicella Vaccine Product and Services
Table 41. Biken Varicella Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Biken Recent Developments/Updates
Table 43. Global Varicella Vaccine Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 44. Global Varicella Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Varicella Vaccine Average Price by Manufacturer (2018-2023) & (USD/Dose)
Table 46. Market Position of Manufacturers in Varicella Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Varicella Vaccine Production Site of Key Manufacturer
Table 48. Varicella Vaccine Market: Company Product Type Footprint
Table 49. Varicella Vaccine Market: Company Product Application Footprint
Table 50. Varicella Vaccine New Market Entrants and Barriers to Market Entry
Table 51. Varicella Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Varicella Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 53. Global Varicella Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 54. Global Varicella Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Varicella Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Varicella Vaccine Average Price by Region (2018-2023) & (USD/Dose)
Table 57. Global Varicella Vaccine Average Price by Region (2024-2029) & (USD/Dose)
Table 58. Global Varicella Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 59. Global Varicella Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 60. Global Varicella Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Varicella Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Varicella Vaccine Average Price by Type (2018-2023) & (USD/Dose)
Table 63. Global Varicella Vaccine Average Price by Type (2024-2029) & (USD/Dose)
Table 64. Global Varicella Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 65. Global Varicella Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 66. Global Varicella Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Varicella Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Varicella Vaccine Average Price by Application (2018-2023) & (USD/Dose)
Table 69. Global Varicella Vaccine Average Price by Application (2024-2029) & (USD/Dose)
Table 70. North America Varicella Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 71. North America Varicella Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 72. North America Varicella Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 73. North America Varicella Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 74. North America Varicella Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 75. North America Varicella Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 76. North America Varicella Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Varicella Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Varicella Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 79. Europe Varicella Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 80. Europe Varicella Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 81. Europe Varicella Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 82. Europe Varicella Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 83. Europe Varicella Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 84. Europe Varicella Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Varicella Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Varicella Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 87. Asia-Pacific Varicella Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 88. Asia-Pacific Varicella Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 89. Asia-Pacific Varicella Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 90. Asia-Pacific Varicella Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 91. Asia-Pacific Varicella Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 92. Asia-Pacific Varicella Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Varicella Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Varicella Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 95. South America Varicella Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 96. South America Varicella Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 97. South America Varicella Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 98. South America Varicella Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 99. South America Varicella Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 100. South America Varicella Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Varicella Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Varicella Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 103. Middle East & Africa Varicella Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 104. Middle East & Africa Varicella Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 105. Middle East & Africa Varicella Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 106. Middle East & Africa Varicella Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 107. Middle East & Africa Varicella Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 108. Middle East & Africa Varicella Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Varicella Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Varicella Vaccine Raw Material
Table 111. Key Manufacturers of Varicella Vaccine Raw Materials
Table 112. Varicella Vaccine Typical Distributors
Table 113. Varicella Vaccine Typical Customers
List of Figures
Figure 1. Varicella Vaccine Picture
Figure 2. Global Varicella Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Varicella Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Injection Examples
Figure 5. Freeze-Dried Powder Examples
Figure 6. Global Varicella Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Varicella Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Kids Injection Examples
Figure 9. Adults Injection Examples
Figure 10. Global Varicella Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Varicella Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Varicella Vaccine Sales Quantity (2018-2029) & (M Doses)
Figure 13. Global Varicella Vaccine Average Price (2018-2029) & (USD/Dose)
Figure 14. Global Varicella Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Varicella Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Varicella Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Varicella Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Varicella Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Varicella Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Varicella Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Varicella Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Varicella Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Varicella Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Varicella Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Varicella Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Varicella Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Varicella Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Varicella Vaccine Average Price by Type (2018-2029) & (USD/Dose)
Figure 29. Global Varicella Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Varicella Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Varicella Vaccine Average Price by Application (2018-2029) & (USD/Dose)
Figure 32. North America Varicella Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Varicella Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Varicella Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Varicella Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Varicella Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Varicella Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Varicella Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Varicella Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Varicella Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Varicella Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Varicella Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Varicella Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Varicella Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Varicella Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Varicella Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Varicella Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Varicella Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Varicella Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Varicella Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Varicella Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Varicella Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Varicella Vaccine Market Drivers
Figure 73. Varicella Vaccine Market Restraints
Figure 74. Varicella Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Varicella Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Varicella Vaccine
Figure 78. Varicella Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
